Deepa Bedi

发表

Enhanced binding and killing of target tumor cells by drug-loaded liposomes modified with tumor-specific phage fusion coat protein.

Tao Wang, Deepa Bedi, V. Petrenko, 2010, Nanomedicine.

Landscape phage ligands for PC3 prostate carcinoma cells.

V. Petrenko, D. Bedi, P. DeInnocentes, 2010, Protein engineering, design & selection : PEDS.

Camptothecin Induces PD-L1 and Immunomodulatory Cytokines in Colon Cancer Cells

U. Manne, D. Bedi, T. Samuel, 2019, Medicines.

Coupling of Scales‐Continuum Mechanics and Molecular Dynamics

Sumit Sharma, D. Bedi, S. Tiwari, 2021 .

Landscape phages and their fusion proteins targeted to breast cancer cells.

V. Petrenko, O. Fagbohun, D. Bedi, 2012, Protein engineering, design & selection : PEDS.

Loss of Neuroligin 4X Induces an Intrinsic Innate Immune Response in TNBC

D. Bedi, C. Yates, T. Samuel, 2021 .

Phage Ligands for Identification of Mesenchymal-Like Breast Cancer Cells and Cancer-Associated Fibroblasts

B. Karanam, D. Bedi, R. Samant, 2018, Front. Oncol..

Molecular Insights into Strengthening of Biomineral Apatite with Carbon Nanofillers: A Simulation Study

Sumit Sharma, Deepa Bedi, S.K. Tiwari, 2024, Materials Chemistry and Physics.

Effect of chirality and defects on tensile behavior of carbon nanotubes and graphene: Insights from molecular dynamics

Sumit Sharma, D. Bedi, S. Tiwari, 2021, Diamond and Related Materials.

Quadruple Negative Breast Cancers (QNBC) Demonstrate Subtype Consistency among Primary and Recurrent or Metastatic Breast Cancer

S. Tripathi, D. Bedi, M. Davis, 2018, Translational oncology.

Selection of Promiscuous Anti-Cancer Phage Proteins for Tumor Targeted Nanomedicines

A. Puzyrev, D. Bedi, F. Bartol, 2015 .

Targeted delivery of siRNA into breast cancer cells via phage fusion proteins.

V. Petrenko, P. Hinterdorfer, A. Ebner, 2013, Molecular pharmaceutics.